Mária Rajtár

Use and Limitations of a Nomogram Predicting the Likelihood of Non-Sentinel Node Involvement after a Positive Sentinel Node Biopsy in Breast Cancer Patients

Lajos Kocsis, Mihály Svébis, Gábor Boross et al. · The American Surgeon · 2004 · 89 citations

Surgical Oncology, Breast Oncology, Diagnosis +21

Predicting Non-Sentinel Lymph Node Status After Positive Sentinel Biopsy in Breast Cancer: What Model Performs the Best in a Czech Population?

Oldřich Coufal, Tomáš Pavlík, Pavel Fabián et al. · Pathology & Oncology Research · 2009 · 65 citations

Breast Oncology, Cancer Detection, Medicine +12

Comparison of vital dye‐guided lymphatic mapping and dye plus gamma probe‐guided sentinel node biopsy in breast cancer

Gábor Cserni, Mária Rajtár, Gábor Boross et al. · World Journal of Surgery · 2002 · 59 citations

Anti-granulocyte immunoscintigraphy and [99mTc]hexamethylpropyleneamine-oxime-labeled leukocyte scintigraphy in inflammatory bowel disease

Miklós Papós, Ferenc Nagy, G Nárai et al. · Digestive Diseases and Sciences · 1996 · 29 citations

Inflammation, Autoimmune Disease, Granulocyte +12

Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.

E. Ambrus, Mária Rajtár, Katalin Ormándi et al. · PubMed · 1997 · 22 citations

Breast Oncology, Medical Imaging, Dmsa Scintigraphy +15